Neurovascular Thrombectomy Devices Market

DelveInsight’s ‘Neurovascular Thrombectomy Devices - Market Insights, Competitive Landscape and Market Forecast–2026’ report delivers an in-depth understanding of Neurovascular Thrombectomy Devices and the historical and forecasted Neurovascular Thrombectomy Devices market trends in the US, EU5 (Germany, France, Spain, Italy, and the United Kingdom) and Japan.


The Neurovascular Thrombectomy Devices market report provides an overview of Neurovascular Thrombectomy Devices, applications of Neurovascular Thrombectomy Devices as well as its PEST Analysis. Additionally, the report provides insight on the Neurovascular Thrombectomy Devices market share of the individual Neurovascular Thrombectomy Devices, current and forecasted Neurovascular Thrombectomy Devices market size from 2018 to 2026 segmented by seven major markets. The report also covers the market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses underlying potential of the market.

Neurovascular Thrombectomy Devices Understanding

Neurovascular Thrombectomy Devices Overview

Thrombectomy is a procedure to eliminate the blood clots that are produced in the blood vessels. To retrieve or kill blood clots in the cerebral region, neurovascular thrombectomy devices are used. Neurovascular thrombectomy devices are used to treat the blockage in the brain which may occur due to many reasons, such as atheroma, thrombus in one or more arteries. The blood clot may lead to may cause fatal complication if left untreated. As per the data presented by the World Health Organization, about 15 million people across the world suffer from stroke. Quick and efficient vessel recanalization is critical for successfully treating acute stroke patients.

Geography Covered

  • The US
  • EU5 (Germany, France, Spain, Italy, and the United Kingdom)
  • Japan

 Study Period: 2018–2026

List of Companies

  • Edward LifeSciences Corporation
  • Stryker
  • Terumo Europe NV
  • Boston Scientific Corporation
  • Medtronic
  • Acandis GmbH
  • Perflow Medical
  • Phenox GmbH
  • Penumbra
  • Johnson and Johnson
  • MicroVention, Inc.

Neurovascular Thrombectomy Devices - Competitive Analysis

This segment of the report provides a brief competitive analysis of Neurovascular Thrombectomy Devices to help understand the competition in the market. It gives a comparative understanding of the products based on parameters such as type of regulatory approval.


Neurovascular Thrombectomy Devices: Market Segmentation


By Device Type

  • Stent Retrievers
  • Aspiration Devices
  • Combination


Neurovascular Thrombectomy Devices: Eligible Patient Population

This segment of the report provides an analysis of the eligible patient pool that incorporate Neurovascular Thrombectomy Devices for their treatment, across 7MM during the study period (2018 and 2026).

Neurovascular Thrombectomy Devices: Market Analysis

This segment illustrates the market of Neurovascular Thrombectomy Devices across the 7MM and how the market is expected to rise in the study period (2018 to 2026), at a significant

CAGR of XX%.


Neurovascular Thrombectomy Devices: Market Dynamics

The report provides insights into the market driving factors and the barriers shaping the Neurovascular Thrombectomy Devices market.


Market Drivers

  • Increase in the Ageing Population
  • Increase in Incidence and Prevalence of Neurovascular Diseases
  • Technological Advancements in Minimally Invasive Products
  • Favorable Reimbursement Policies
  • Acquisitions and Partnerships as a Part of the Growth Strategy


Market Barriers

  • Complications with the Implantations of Neurovascular Thrombectomy Devices
  • Lack of Skilled and Trained Professionals
  • Availability of Alternative Products
  • Adverse Events and Product Recalls

KOL Views

To keep up with the market trends, we take KOLs and SME’s opinion working in Neurovascular Thrombectomy Devices domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Neurovascular Thrombectomy Devices market trend. This will support the clients in making informed business decisions by identifying the overall scenario of the market and the unmet needs.

Scope of the Report

  • The report covers the descriptive overview of Neurovascular Thrombectomy Devices, explaining its applications, advantages, and limitations, etc.
  • Additionally, an all-inclusive account of the currently available Neurovascular Thrombectomy Devices is provided, which will have an impact on the future market of Neurovascular Thrombectomy Devices.
  • A detailed review of Neurovascular Thrombectomy Devices market; historical and forecasted market size is included in the report, covering devices outreach in the 7MM.
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the Neurovascular Thrombectomy Devices market.

Report Highlights

  • The report covers descriptive overview of the Neurovascular Thrombectomy Devices, explaining its applications, working mechanism, etc.
  • The report is a comprehensive account of marketed devices present in the Neurovascular Thrombectomy Devices market.
  • The report also reviews the detailed historical and forecasted Neurovascular Thrombectomy Devices market, including assessing the outreach in 7 MM.
  • The report helps in developing business strategies by understanding trends shaping and driving the Neurovascular Thrombectomy Devices market.

Neurovascular Thrombectomy Devices Report Key Strengths

  • 6 Years Forecast
  • 7MM Coverage
  • Competitive Landscape
  • PEST Analysis
  • Market Size

Neurovascular Thrombectomy Devices Report Assessment

  • Marketed Product profiles
  • Key Products and Key Players
  • Market Drivers and Barriers
  • Market Forecast
  • KOL’S views
  • PEST Analysis

Key Questions

Market Insights:

  • What was the Neurovascular Thrombectomy Devices market share (%) distribution in 2018 and how it will look like in 2026?
  • What will be the Neurovascular Thrombectomy Devices total market size as well as market size by devices across the 7MM during the forecast period (2018–2026)?
  • What are the key findings pertaining to the market across the 7MM and which country will have the largest Neurovascular Thrombectomy Devices market size during the forecast period (2018–2026)?
  • At what CAGR, the Neurovascular Thrombectomy Devices market is expected to grow in the 7MM during the forecast period (2018–2026)?
  • What will be the Neurovascular Thrombectomy Devices market outlook across the 7MM during the forecast period (2018–2026)?
  • What will be the Neurovascular Thrombectomy Devices market growth till 2026 and what will be the resultant market size in the year 2026?
  • How will the market drivers, barriers and future opportunities affect the market dynamics and a subsequent analysis of the associated trends?


Competitive Landscape:

  • What are the current devices available in the Neurovascular Thrombectomy Devices?
  • What is the Neurovascular Thrombectomy Devices available in the market, their product description, regulatory milestones, product development activities, research and development activities etc.?
  • How many key players are developing Neurovascular Thrombectomy Devices?
  • What are the key collaborations (Industry–Industry), Mergers and acquisitions, licensing activities related to the Neurovascular Thrombectomy Devices?
  • What are the key designations that have been granted for the current Neurovascular Thrombectomy Devices?
  • What are the 7MM countries historical and forecasted market of Neurovascular Thrombectomy Devices?

 

Frequently Asked Questions


What is Neurovascular Thrombectomy Devices?

Neurovascular Thrombectomy is a procedure to eliminate the blood clots in the blood vessels. These devices are used to treat the brain’s blockage, which may occur for many reasons, such as atheroma and thrombus in one or more arteries.


Who are the leading companies in the Neurovascular Thrombectomy Devices Market Landscape?

The leading companies that are working in the Neurovascular Thrombectomy Devices Market are Edwards Lifesciences Corporation, Medtronic, Stryker, Penumbra, Inc. Terumo Corporation, MicroVention Inc., Acandis GmbH, Boston Scientific, Johnson & Johnson, and others.


How is Neurovascular Thrombectomy Devices Market Segmented?

The Neurovascular Thrombectomy Devices Market is segmented on the basis of Aspiration Catheter, Stent Retrievers, and Combination Procedures.


At what CAGR is the Neurovascular Thrombectomy Devices Market expected to rise?

Neurovascular Thrombectomy Devices Market is expected to rise at a CAGR of 14.27% during the study period of 2018-2026 in the 7MM.


Which country holds the major share of the Neurovascular Thrombectomy Devices Market?

The United States holds the largest market share for the Neurovascular Thrombectomy Devices Market in 2021.


What is the Impact of Covid-19 on Neurovascular Thrombectomy Devices Market?

The Neurovascular Thrombectomy Devices Market had observed a positive shift in market revenues due to the Covid 19 in 2020. The report includes the factors that are contributing to this significant increase in detail.

1 Key Insights

2 Report Introduction

3 Executive Summary Of Neurovascular Thrombectomy Devices

4 Neurovascular Thrombectomy Devices: Background And Overview

4.1 Introduction

4.2 Causes And Symptoms

4.2.1 Causes Of Neurovascular Conditions

4.2.2 Symptoms

4.3 Treatment Options For Stroke

4.3.1 Antiplatelet Drug (Antiaggregant) Therapy

4.3.2 Thrombolytic Therapy

4.3.3 Neurothrombectomy Devices

4.4 Risks Associated With The Neurovascular Thrombectomy Devices

4.5 Advantages Of The Neurovascular Thrombectomy Devices

4.6 Disadvantages Of The Neurovascular Thrombectomy Devices

5. Neurovascular Thrombectomy Devices: Regulatory Approval And Reimbursement Scenario

5.1 Neurovascular Thrombectomy Devices:Regulatory Approval

5.1.1 United States Regulation Of Neurovascular Thrombectomy Devices

5.1.2 European Regulation Of Neurovascular Thrombectomy Devices

5.1.3 Japan Regulation Of Neurovascular Thrombectomy Devices

5.2 Neurovascular Thrombectomy Devices:Reimbursement Scenario

5.2.1 Reimbursement Scenario In United States

5.2.2 Reimbursement Scenario In Europe

5.2.3 Reimbursement Scenario In Japan

6 Neurovascular Thrombectomy Devices: Marketed Product Profiling

6.1 Key Cross Competition Based On Device Type

6.2 Company And Product Profiles

6.2.1 Edwards Lifesciences

6.2.2 Medtronic Plc

6.2.3 Stryker Corporation

6.2.4 Penumbra Inc.

6.2.5 Terumo Corporation

6.2.6 Microvention Inc

6.2.7 Acandis Gmbh

6.2.8 Boston Scientific Corporation

6.2.9 Johnson & Johnson

6.2.10 Perflow Medical

6.2.11 Phenox Gmbh

7 Neurovascular Thrombectomy Devices: Emerging Devices

7.1 Anaconda Biomeds S.L.

7.1.1 Business Overview

7.1.2 Product Portfolio – Ancd Advanced Thrombectomy System

7.2 Mivi Neuroscience, Inc.

7.2.1 Business Overview

7.2.2 Product Portfolio – Q Aspiration Catheter

7.2.3 Recent Developments

7.2.4 Clinical Trial

7.3 Microvention Inc

7.3.1 Product Portfolio- Sofia® Flow Plus 6f Aspiration Catheter With The Gomco 405 Aspiration Pump And Tubing Kit

7.3.2 Clinical Trial

8 Assumptions And Rationale

8.1 Eligible Patient Population For Neurovascular Thrombectomy Devices

8.2 Market Analysis For Neurovascular Thrombectomy Devices

9 Neurovascular Thrombectomy Devices: Eligible Patient Population

9.1 7mm: Eligible Patient Population For Neurovascular Thrombectomy Devices

9.2 The United States: Eligible Patient Population For Neurovascular Thrombectomy Devices

9.3 Germany: Eligible Patient Population For Neurovascular Thrombectomy Devices

9.4 France: Eligible Patient Population For Neurovascular Thrombectomy Devices

9.5 Italy: Eligible Patient Population For Neurovascular Thrombectomy Devices

9.6 Spain: Eligible Patient Population FornNeurovascular Thrombectomy Devices

9.7 United Kingdom: Eligible Patient Population For Neurovascular Thrombectomy Devices

9.8 Japan: Eligible Patient Population For Neurovascular Thrombectomy Devices

10 Neurovascular Thrombectomy Devices: Market Analysis

10.1 The Market Size Of Neurovascular Thrombectomy Devices In The 7mm

10.1.1 The Market Size Of Neurovascular Thrombectomy Devices In The 7mm By Device Type

10.2 United States Market Analysis (Neurovascular Thrombectomy Devices)

10.2.1 The Market Size Of Neurovascular Thrombectomy Devices In The United States By Device Type

10.3 Germany Market Analysis (Neurovascular Thrombectomy Devices)

10.3.1 The Market Size Of Neurovascular Thrombectomy Devices In Germany By Device Type

10.4 France Market Analysis (Neurovascular Thrombectomy Devices)

10.4.1 The Market Size Of Neurovascular Thrombectomy Devices In France By Device Type

10.5 Italy Market Analysis (Neurovascular Thrombectomy Devices)

10.5.1 The Market Size Of Neurovascular Thrombectomy Devices In Italy By Device Type

10.6 Spain Market Analysis (Neurovascular Thrombectomy Devices)

10.6.1 The Market Size Of Neurovascular Thrombectomy Devices In Spain By Device Type

10.7 United Kingdom Market Analysis (Neurovascular Thrombectomy Devices)

10.7.1 The Market Size Of Neurovascular Thrombectomy Devices In United Kingdom By Device Type

10.8 Japan Market Analysis (Neurovascular Thrombectomy Devices)

10.8.1 The Market Size Of Neurovascular Thrombectomy Devices In Japan By Device Type

11 Kol's Views

12 Market Drivers

13 Market Barriers

14 Unmet Needs

15 Pest Analysis

16 Appendix

16.1 Bibliography

16.2 Report Methodology

17 Delveinsight Capabilities

18 Disclaimer

19 About Delveinsight

List of Table

Table 1: Summary Of Neurovascular Thromactomy Devices , Market, Eligible Patient Pool, And Key Events (2018–2026)

Table 2: Reimbursement Coverage For Mechanical Thrombectomy In The Us

Table 3: Reimbursement Status In Europe

Table 4: Assessment Based On Stage

Table 5: Key Cross Of Marketed Neurovascular Thrombectomy Devices Based On Their Device Type

Table 6: Company Profile: Edwards Lifesciences

Table 7: Company Profile: Medtronic Plc

Table 8: Company Profile: Stryker Corporation

Table 9: Company Profile: Penumbra, Inc

Table 10: Company Profile: Terumo Corporation

Table 11: Company Profile: Microvention

Table 12: Company Profile: Acandis Gmbh

Table 13: Company Profile: Boston Scientific Corporation

Table 14: Company Profile: Johnson & Johnson Inc.

Table 15: Company Profile: Perflow Medical Ltd.

Table 16: Company Profile: Phenox Gmbh

Table 17: Company Profile: Anaconda Biomed S.L.

Table 18: Company Profile: Mivi Neuroscience Inc.

Table 19: Eligible Patient Population For Neurovascular Thrombectomy Devices In The 7mm (2018–2026)

Table 20: Eligible Patient Population For Neurovascular Thrombectomy Devices In The United States (2018–2026)

Table 21: Eligible Patient Population For Neurovascular Thrombectomy Devices In Germany (2018–2026)

Table 22: Eligible Patient Population For Neurovascular Thrombectomy Devices In France (2018-2026)

Table 23: Eligible Patient Population For Neurovascular Thrombectomy Devices In Italy (2018–2026)

Table 24: Eligible Patient Population For Neurovascular Thrombectomy Devices In Spain (2018–2026)

Table 25: Eligible Patient Population For Neurovascular Thrombectomy Devices In The Uk (2018–2026)

Table 26: Eligible Patient Population For Neurovascular Thrombectomy Devices In Japan (2018–2026)

Table 27: Market Size Of Neurovascular Thrombectomy Devices In The 7mm In Usd Million (2018–2026)

Table 28: Market Size Of Neurovascular Thrombectomy Devices In The 7mm In Usd Million By Device Type (2018–2026)

Table 29: Market Size Of Neurovascular Thrombectomy Devices In The United States In Usd Million (2018-2026)

Table 30: Market Size Of Neurovascular Thrombectomy Devices In The United States In Usd Million By Device Type (2018– 2026)

Table 31: Market Size Of Neurovascular Thrombectomy Devices In Germany In Usd Million (2018–2026)

Table 32: Market Size Of Neurovascular Thrombectomy Devices In Germany In Usd Million By Device Type (2018–2026)

Table 33: Market Size Of Neurovascular Thrombectomy Devices In France In Usd Million (2018-2026)

Table 34: Market Size Of Neurovascular Thrombectomy Devices In France In Usd Million By Device Type (2018–2026)

Table 35: Market Size Of Neurovascular Thrombectomy Devices In Italy In Usd Million (2018–2026)

Table 36: Market Size Of Neurovascular Thrombectomy Devices In Italy In Usd Million By Device Type (2018–2026

Table 37: Market Size Of Neurovascular Thrombectomy Devices In Spain In Usd Million (2018-2026)

Table 38: Market Size Of Neurovascular Thrombectomy Devices In Spain In Usd Million By Device Type (2018–2026)

Table 39: Market Size Of Neurovascular Thrombectomy Devices In The United Kingdom In Usd Million (2018-2026)

Table 40: Market Size Of Neurovascular Thrombectomy Devices In United Kingdom In Usd Million By Device Type (2018– 2026)

Table 41:Market Size Of Neurovascular Thrombectomy Devices In Japan In Usd Million (2018-2026)

Table 42: Market Size Of Neurovascular Thrombectomy Devices In Japan In Usd Million By Device Type (2018–2026)

List of Figures

Figure 1: Treatment Process

Figure 2: Class Ii Device Approval Processes In The United States

Figure 3: Approval Processes In European Countries

Figure 4: Class Ii Device Approval Processes In Japan

Figure 5: Healthcare Reimbursement System In The Us

Figure 6: Key Cross Competition On The Basis Of Device Type

Figure 7: Company Revenue (As Of December 31 Of Each Year): Edwards Lifesciences

Figure 8: R&D Expenses: Edwards Lifesciences

Figure 9: Fogarty Arterial Embolectomy Catheter

Figure 10: Fogarty Fortis Arterial Embolectomy Catheter

Figure 11: Edwards Silicone Embolectomy Catheter

Figure 12: Fogarty Thru-Lumen Embolectomy Catheter

Figure 13: Company Revenue (As Of April Of Each Year): Medtronic Plc

Figure 14: R&D Expenses: Medtronic Plc

Figure 15: Riptide Aspiration System

Figure 16: Solitaire X

Figure 17: Company Revenue (As Of December 31 Of Each Year): Stryker Corporation

Figure 18: R&D Expenses: Stryker Corporation

Figure 19: Axs Universal

Figure 20: Trevo Nxt Provue Retriever

Figure 21: Trevo Xp Provue Retriever

Figure 22: Cat™ 6 Distal Access Catheter

Figure 23: Company Revenue (As Of December 31 Of Each Year): Penumbra, Inc.

Figure 24: R&D Expenses: Penumbra, Inc.

Figure 25: The Penumbra System

Figure 26: Penumbra System® Jet 7 Reperfusion Catheter

Figure 27: Penumbra Jet™ D Reperfusion Catheter

Figure 28: Penumbra System® Ace 68 Reperfusion Catheter

Figure 29: Penumbra System® 3d Revascularization Device

Figure 30: Penumbra System® Max™ Reperfusion Catheters

Figure 31: Company Revenue (As Of March 31 Of Each Year): Terumo Corporation

Figure 32: R&D Expenses: Terumo Corporation

Figure 33: Eliminate Aspiration Catheter

Figure 34: Priorityone Aspiration Catheter

Figure 35: Company Revenue (As Of March 31 Of Each Year): Microvention

Figure 36: R&D Expenses: Microvention

Figure 37: Sofia Plus Catheters

Figure 38: Aperio Thrombectomy Device

Figure 39: Aperio Hybrid Thrombectomy Device

Figure 40: Company Revenue: Boston Scientific Corporation

Figure 41: R&D Expenses: Boston Scientific Corporation

Figure 42: Fetch2 Thrombectomy Catheter

Figure 43: Company Revenue (As Of December 31 Of Each Year): Johnson & Johnson

Figure 44: R&D Expenses: Johnson & Johnson

Figure 45: Embotrap Ii Revascularization Device R&D Expenses

Figure 46: Revive Se™ Thrombectomy Device

Figure 47: Embotrap® Iii Revascularization Device

Figure 48: Embovac™ Aspiration Catheter

Figure 49: Cerebase™ Da Guide Sheath

Figure 50: Stream Dynamic Neuro Thrombectomy Net

Figure 51: Preset Lite

Figure 52: Ancd Advanced Thrombectomy System

Figure 53: Q Aspiration Catheter

Figure 54: Eligible Patient Population For Neurovascular Thrombectomy Devices In The 7mm (2018–2026)

Figure 55: Eligible Patient Population For Neurovascular Thrombectomy Devices In The United States (2018–2026)

Figure 56: Eligible Patient Population For Neurovascular Thrombectomy Devices In Germany (2018–2026)

Figure 57: Eligible Patient Population For Neurovascular Thrombectomy Devices In France (2018-2026)

Figure 58: Eligible Patient Population For Neurovascular Thrombectomy Devices In Italy (2018–2026)

Figure 59: Eligible Patient Population For Neurovascular Thrombectomy Devices In Spain (2018–2026)

Figure 60: Eligible Patient Population For Neurovascular Thrombectomy Devices In The United Kingdom (2018–2026)

Figure 61: Eligible Patient Population For Neurovascular Thrombectomy Devices In Japan (2018-2026)

Figure 62: Market Size Of Neurovascular Thrombectomy Devices In The 7mm In Usd Million (2018–2026)

Figure 63: Market Size Of Neurovascular Thrombectomy Devices In The 7mm In Usd Million By Device Type (2018–2026)

Figure 64: Market Size Of Neurovascular Thrombectomy Devices In The United States In Usd Million (2018-2026)

Figure 65: Market Size Of Neurovascular Thrombectomy Devices In The United States In Usd Million By Device Type (2018–2026)

Figure 66: Market Size Of Neurovascular Thrombectomy Devices In Germany In Usd Million (2018-2026)

Figure 67: Market Size Of Neurovascular Thrombectomy Devices In Germany In Usd Million By Device Type (2018–2026)

Figure 68: Market Size Of Neurovascular Thrombectomy Devices In France In Usd Million (2018–2026)

Figure 69: Market Size Of Neurovascular Thrombectomy Devices In France In Usd Million By Device Type (2018–2026)

Figure 70: Market Size Of Neurovascular Thrombectomy Devices In Italy In Usd Million (2018-2026)

Figure 71: Market Size Of Neurovascular Thrombectomy Devices In Italy In Usd Million By Device Type (2018–2026)

Figure 72: Market Size Of Neurovascular Thrombectomy Devices In Spain In Usd Million (2018–2026)

Figure 73: Market Size Of Neurovascular Thrombectomy Devices In Spain In Usd Million By Device Type (2018–2026)

Figure 74: Market Size Of Neurovascular Thrombectomy Devices In The United Kingdom In Usd Million (2018-2026)

Figure 75: Market Size Of Neurovascular Thrombectomy Devices In United Kingdom In Usd Million By Device Type (2018–2026)

Figure 76: Market Size Of Neurovascular Thrombectomy Devices In Japan In Usd Million (2018-2026)

Figure 77: Market Size Of Neurovascular Thrombectomy Devices In Japan In Usd Million By Device Type (2018–2026)

• Edward LifeSciences Corporation

• Stryker

• Terumo Europe NV

• Boston Scientific Corporation

• Medtronic

• Acandis GmbH

• Perflow Medical

• Phenox GmbH

• Penumbra

• Johnson and Johnson

• MicroVention, Inc.

  • Tags:
  • Neurovascular Thrombectomy Devices
  • Neurovascular Thrombectomy Devices...
  • Neurovascular Thrombectomy Devices...
  • Neurovascular Thrombectomy Devices...
  • Neurovascular Thrombectomy Devices...
  • Neurovascular Thrombectomy Devices...
  • Neurovascular Thrombectomy Devices...
  • Neurovascular Thrombectomy Devices...
  • Neurovascular Thrombectomy Devices...
  • Neurovascular Thrombectomy Devices...

Forward to Friend

Need A Quote